Cargando…

Association of Combined p73 and p53 Genetic Variants with Tumor HPV16-Positive Oropharyngeal Cancer

p53 and p73 interact with human papillomavirus (HPV) E6 and E7 oncoproteins. The interplay between p53 and p73 and HPV16 may lead to deregulation of cell cycle and apoptosis, through which inflammation/immune responses control the HPV clearance and escape of immune surveillance, and subsequently con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhongqiu, Sturgis, Erich M., Guo, Wei, Song, Xicheng, Zhang, Fenghua, Xu, Li, Wei, Qingyi, Li, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327667/ https://www.ncbi.nlm.nih.gov/pubmed/22523600 http://dx.doi.org/10.1371/journal.pone.0035522

Ejemplares similares

Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck
por: Wang, Zhongqiu, et al.
Publicado: (2012)

MicroRNA Variants Increase the Risk of HPV-Associated Squamous Cell Carcinoma of the Oropharynx in Never Smokers
por: Song, Xicheng, et al.
Publicado: (2013)

Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck
por: Zhou, Ziyuan, et al.
Publicado: (2012)

Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma
por: Jin, Lei, et al.
Publicado: (2013)

Genetic Variation in MDM2 and p14 (ARF) and Susceptibility to Salivary Gland Carcinoma
por: Jin, Lei, et al.
Publicado: (2012)

A functional variant at miRNA-122 binding site in IL-1α 3′ UTR predicts risk of recurrence in patients with oropharyngeal cancer
por: Wang, Chengyuan, et al.
Publicado: (2016)

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy
por: Chen, Xingming, et al.
Publicado: (2016)

Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck
por: Sun, Yan, et al.
Publicado: (2016)

GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy
por: Sun, Peng, et al.
Publicado: (2023)

HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan
por: Adilbay, Dauren, et al.
Publicado: (2018)

Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx
por: Wang, Chengyuan, et al.
Publicado: (2016)

Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx
por: Zhang, Yang, et al.
Publicado: (2017)

Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer
por: Chi, Jeffrey, et al.
Publicado: (2020)

HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
por: Wasserman, Jason K., et al.
Publicado: (2017)

Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer
por: Queiroz, Cleberson Jean dos Santos, et al.
Publicado: (2014)

Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites
por: Guan, Xiaoxiang, et al.
Publicado: (2013)

Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners
por: Tsao, Anne S., et al.
Publicado: (2016)

Correction to: HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
por: Wasserman, Jason K., et al.
Publicado: (2018)

P63 and P73 Activation in Cancers with p53 Mutation
por: Cai, Bi-He, et al.
Publicado: (2022)

p53, p63 and p73 in the wonderland of S. cerevisiae
por: Billant, Olivier, et al.
Publicado: (2017)

The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive Radiotherapy
por: Zhang, Hua, et al.
Publicado: (2018)

Comparative Analysis of P73 and P53 Regulation and Effector Functions
por: Fang, Li, et al.
Publicado: (1999)

HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
por: da Costa, Allini Mafra, et al.
Publicado: (2017)

Induction Chemotherapy for p16 Positive Oropharyngeal Squamous Cell Carcinoma
por: Saito, Yuki, et al.
Publicado: (2016)

Differences in clinical and imaging characteristics between p16-positive non-smokers and p16-positive smokers or p16-negative patients in oropharyngeal carcinoma
por: Trinh, Jean-Michel, et al.
Publicado: (2021)

Prognostic utility of HPV specific testing in addition to p16 immunohistochemistry in oropharyngeal squamous cell carcinoma
por: Sathasivam, H P, et al.
Publicado: (2018)

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
por: Taberna, Miren, et al.
Publicado: (2018)

Proinflammatory Cytokines and Bile Acids Upregulate ΔNp73 Protein, an Inhibitor of p53 and p73 Tumor Suppressors
por: Zaika, Elena, et al.
Publicado: (2013)

Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma
por: Xie, Xiujie, et al.
Publicado: (2013)

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
por: Balk, Matthias, et al.
Publicado: (2023)

p53- and p73-independent activation of TIGAR expression in vivo
por: Lee, P, et al.
Publicado: (2015)

Hypermethylation of nc886 in HPV-positive oropharyngeal cancer and its clinical implications: An epigenome-wide association study
por: Xu, Yifan, et al.
Publicado: (2022)

A Critical Role for p53 during the HPV16 Life Cycle
por: Fontan, Christian T., et al.
Publicado: (2022)

Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status
por: Wendt, Malin, et al.
Publicado: (2021)

MDM4 genetic variants predict HPV16-positive tumors of patients with squamous cell carcinoma of the oropharynx
por: Lu, Zhongming, et al.
Publicado: (2017)

p53 Is Regulated in a Biphasic Manner in Hypoxic Human Papillomavirus Type 16 (HPV16)-Positive Cervical Cancer Cells
por: Zhuang, Linhan, et al.
Publicado: (2020)

p53, p63 and p73 expression and angiogenesis in keratocystic odontogenic tumors
por: Chandrangsu, Soranun, et al.
Publicado: (2016)

DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma
por: Smith, Eric A., et al.
Publicado: (2017)

The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma
por: Pastrez, Paula Roberta Aguiar, et al.
Publicado: (2017)

HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers
por: Lulić, Lucija, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cu6ik2gdidbn51kvbn4kc0ojsn